, a serious complications of neuroleptic chronic use, has no effective therapy yet. We performed an experiment to study the action on TD, of the calcium channel blockers (CCB) drugs, verapamil and flunarizine. We obtained the TD model in rats, administering haloperidol for a 21-day period. After this, the stereotyped movement induced by apomorphyne was rated.
stereotyped movements in rats 15, 16, 23 . i n spite of all therapeutic trials, no signi ficant improve has been observed in TD. Although, persistent researchers have been trying to find efficacious alternatives i>9>io.
Recent studies have demonstrated side effects of calcium channel blockers (GCB) upon the CNS. Acathysia, depression, parkinsonism and dyskinesia, all se condary to flunarizine chronic use 7, is, 19,20 as well as dysgeusia and dysosmia 1 ? induced by nifedipine may be evidences that these drugs act on neurotransmission. The influence of such drugs on DA system (more precisely, the nigrostriatal system), brought us to set up a behavioural study by means of an experimental model of TD in rats, making use of verapamil and flunarizine, pharmacologically distinct calcium channel blockers 13 ,25.
MATERIAL AND METHODS
Animals -Male Wistar rats aged between 3 and 4 months were used, and kept in cages in 5-animal groups in a bioterium under (lighting and temperature controlled conditions. Drugs -Solutions of 5 mg/ml haloperidol, 2 mg/ml apomorphine, 2 mg/ml verapamil, prepared with distilled water, and a flunarizine suspension prepared with 2% Tween (v/v). The drugs were administered intraperitoneally (i.p.) in a volume of 1 ml/kg.
Stereotyped behaviour -The rats underwent a 21-day treatment with haloperidol, being kept in 5-animal cages. Apomorphine was given on the 24th day of the experiment, for the stereotyped movement testing.
In the acute protocols the test was carried out on ithe 28th day, and he calcium channel blocker or (a control solution was given 20 minutes before apo morphine.
Chronic protocols were carried out with apomorphine exclusive administration on the day of testing.
In the provocative test, as well as in the experimental test, the animals were placed in individual cages for the grading of duration and intensity of stereotyped movement. Then, each animal was observed every 5 minutes for 30 seconds, according to a stereotyped grading scale, adopted for use at the Department of Psychobiology, Escola Paulista de Medicina ( Table 1) .
The experiment was deemed terminated whenever the animal onde again presented with normal exploratory reactions, establishing grooming as a criterion for finishing the test.
Technique:
Acute testing -Eighty rats were treated for 21 days with haloperidol 5 mg/kg i.p., and were divided into 8 groups with 10 (animals each. On the 24th day of the experiment apo morphine was administered i.p., 2 mg/kg, as a provocative test for stereotyped movements. On the 28th day, an experimental test with calcium channel blockers was set up. Chronic testing I -Sixty rats were treated for 21 days with haloperidol 5 mg/kg i.p., and were divided into 6 groups with 10 animals each. On the 24th day of the experiment apo morphine was administered i.p., 2 mg/kg, as a provocative test for stereotyped movements. From the 25th duay on, CCB were administered. Experiments with verapamil: verapamil was administered i.p. from the 25th to the 32nd day, in 4 and 8 mg/kg doses, as well as saline solution 0.9% as a control. Apomorphine 2 mg/kg was administered i.p. on the 32nd day of the experiment, followed by the evaluation of stereo typed behaviour as already described.
Experiments with flunarizine: flunarizine was administered i.p. from the 25th to the 31st day, in 3 and 6 mg/kg doses, as well as a Tween 2% suspension asi a control. Apomorphine 2 mg/kg was administered i.p. on the 32nd day of the experiment, followed by the evaluation of stereotyped behaviour as (already described.
Chronic testing II -Sixty rats were divided into 6 groups with 10 animals each, and were treated for 21 days with haloperidol 5 mg/k i.p. associated to CCB. Experiments with verapamil: the drug was administered i.p. in 4 and 8 mg/kg doses, as well as saline 0.9% as> a control, in association with the neuroleptic.
On the 24th day of the experiment an experimental test with apomorphine 2 mg/kg i.p. was carried out, followed by the. evaluation of stereotyped behaviour as already described.
Experiments with flunarizine: the drug was administered i.p. in 3 and 6 mg/kg doses, as well as a Tween 2% suspension as a control, in association with the neuroleptic. On the 24th day of the experiment an experimental test with apomorphine 2 mg/kg i.p. was carried out, follow ed by the evaluation of stereotyped behaviour as already described. CCB seem to mimick the effects of extracellular deprivation of calcium. Calcium ion is important in several biological processes, including cellular me tabolism and neurotransmission. Reactions involving calcium in the homeostasis take place in specific proteins that bind to the ion inhibiting or activating enzymes involved in different processes, some of which still obscure 24, 25 .
In our experiments we attempted to show the action of verapamil and flunarizine, pharmacologically distinct CCB 13 » 2 5, in the hypersensitization of post synaptic striatal DA receptors, manifested through the stereotyped behaviour of the animals. These substances were acutely and chronically employed by us; in the last case we noted their actions in association with haloperidol, and after hypersensitization of postsynaptic striatal receptors by the neuroleptic.
Acute administration of verapamil, in the doses adopted in our experiments, do demostrate an increase in stereotyped behaviour in the animals. This could be resulted from a mechanism of action other than its known CCB action. It could still be acting synergistically with apomorphine in the DA system. In the doses employed by us, which are relatively low in relation to other studies, verapamil might be interacting with presynaptic receptors in a similar way to DA antago nists. It is known that low concentrations of these drugs increase the release of dopamine, due to the action on auto-receptors, which are calcium-dependent. DA agonists reduce this release, while antagonists increase it 27.
The effects of chronically administered verapamil, after hypersensitization of postsynaptic DA receptors seem to be evident. The reduction of stereotyped behaviour in rats may suggest that this substance have cumulative properties on DA receptors and, in consequence, could reduce receptor hypersensitivity to the neurotransmitter manifested by stereotyped behaviour. This may result from the development of subsensitivity at the DA receptor, induced by the CCB, or even by another mechanism different from its action on calcium channels. Studies employing rabbit hypothalamus have shown an increase on norepinephrine release, under low concentrations of verapamil, resulting from a blockade to auto-receptor due to specific properties of antagonism to alpha-2 adrenoceptor 8. Low verapamil doses administered to a TD model in rats did not show any effect on stereotyped behaviour 6,21 while high doses suppressed both hyperkinesia and dyskinesia in these animals 6. At high concentrations, verapamil tends to inhibit the release of dopamine and acetylcholine in the CNS, by blocking striatal DA receptors 2 6 .
Despite its inhibitory effect upon stereotyped behaviour when chronically used after hypersentization of postsynaptic striatal DA receptors, if verapamil is given along with haloperidol, it does not prevent the development of receptor hypersensitivity resulting from neuroleptic prolonged use. Although we did not observed the influence of verapamil on stereotyped behaviour in rats, other studies have shown different actions for this CCB. Chronic high dose use of verapamil or dilthiazem along with haloperidol administration for 28 days in rats, prevented the development of behavioural hyperactivity under apomorphine use; nevertheless, the same was not verified with nifedipine use 12 .
Flunarizine testing did not show any influence on stereotyped behaviour in the animals, in the employed doses. Yet, other protocols using high acute doses of flunarizine and nifedine in mice showed reduced behavioural hyperactivity in responses to amphetamine. Consequently, one cannot state that this drug has no effect on TD; maybe at higher doses this can be demonstrated. CCB can decrease calcium utilization during the process of cellular activation. This may point to an important role for calcium in TD, since the ion is necessary for some metabolic processes, and for neurotransmission.
Some investigators have shown a reduction of dyskinetic movements in schizophrenic patients presenting wit TD secondary to neuroleptic use, by the use both of verapamil 2 and dilthiazem 22. This could be a demonstration of the effect of CCB substances upon TD. As all therapeutic trials have not so far offered any efficacious treatment of TD, CCB substances might prove to be a new choice to solve the problem.
